연구성과로 돌아가기

2021 연구자 정보 (482 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Han, Sang Hak
(Han, SH)
Hallym Univ, Dept Pathol, Coll Med, Chunchon, South Korea
Hallym Univ, Coll Med, Dept Pathol, Chunchon, South Korea


[JCR상위 19.9] Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
[JCR상위 16.5] Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease
SCIE 16.5 GASTROENTEROLOGY & HEPATOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL;ONCOLOGY
bykim@chunlab.com;ktsuk@hallym.ac.kr;
ktsuk@hallym.ac.kr;rome73@snu.ac.kr;
Hong, Gun Young
(Hong, GY)
Kwangju Christian Hosp, Dept Internal Med, Gwangju, South Korea

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Jung, Young Kul
(Jung, YK)
Korea Univ, Dept Internal Med, Coll Med, 73 Goryeodae Ro, Seoul 02841, South Korea
0000-0002-6566-1382
Jung, Young Kul
[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Kang, Hyun-Jae
(Kang, HJ)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea D-6121-2012
kang, Hyun-Jae
0000-0002-3500-1746
kang, Hyun-Jae
[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry SCIE 19.9 CARDIAC & CARDIOVASCULAR SYSTEMS hanname@hanmail.net;
Kang, Jeehoon
(Kang, J)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea


[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry
[JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention
SCIE 4.8 CARDIAC & CARDIOVASCULAR SYSTEMS
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY
hanname@hanmail.net;
myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp;
Khan, Arif
(Khan, A)
교신저자 Nord Univ, Fac Biosci & Aquaculture, Genom Grp, N-8049 Bodo, Norway HMV-3165-2023
khan, Arif

[JCR상위 19.9] The dynamic history of gymnosperm plastomes: Insights from structural characterization, comparative analysis, phylogenomics, and time divergence SCIE 19.9 GENETICS & HEREDITY;PLANT SCIENCES latifepm78@yahoo.co.uk;ijlee@knu.ac.kr;
Ki, You-Jeong
(Ki, YJ)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
0000-0003-0102-2810
Ki, You-Jeong
[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry SCIE 19.9 CARDIAC & CARDIOVASCULAR SYSTEMS hanname@hanmail.net;
Kim, Byoung Kook
(Kim, BK)
Chong Kun Dang Bio Res Inst, Ansan, South Korea
Chong Kun Dang Bio Res Inst, Gyeonggi Do, South Korea


[JCR상위 19.9] Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
[JCR상위 16.5] Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease
SCIE 16.5 GASTROENTEROLOGY & HEPATOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL;ONCOLOGY
bykim@chunlab.com;ktsuk@hallym.ac.kr;
ktsuk@hallym.ac.kr;rome73@snu.ac.kr;
Kim, Byung Yong
(Kim, BY)
교신저자 ChunLab Inc, Dept Microbiome, Seoul, South Korea
ChunLab Inc, Seoul, South Korea
JLL-7806-2023
Kim, Byung-Yong
0000-0002-4229-8859
Kim, Byung-Yong
[JCR상위 19.9] Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
[JCR상위 16.5] Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease
SCIE 16.5 GASTROENTEROLOGY & HEPATOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL;ONCOLOGY
bykim@chunlab.com;ktsuk@hallym.ac.kr;
ktsuk@hallym.ac.kr;rome73@snu.ac.kr;
Kim, Chong-Jin
(Kim, CJ)
Kyung Hee Univ, Dept Internal Med, Coll Med, Seoul, South Korea
Kyunghee Univ Hosp Gangdong, Seoul 05278, South Korea
Kyung Hee Univ, Dept Internal Med, East West Neo Med Ctr, Seoul, South Korea
Kyung Hee Univ, East West Neo Med Ctr, Dept Internal Med, Seoul, South Korea
AAY-6890-2021
Kim, Jin Sug

[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry
[JCR상위 39.3] Effects of Asian dust-derived particulate matter on ST-elevation myocardial infarction: retrospective, time series study
Derivation and validation of a combined in-hospital mortality and bleeding risk model in acute myocardial infarction
[JCR상위 42.3] Variation in treatment strategy for non-ST segment elevation myocardial infarction: A multilevel methodological approach
SCIE
ESCI
19.9 CARDIAC & CARDIOVASCULAR SYSTEMS
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
hanname@hanmail.net;
hokim@snu.ac.kr;
ljhmh75@knu.ac.kr;
Kim, Dong Joon
(Kim, DJ)
Hallym Univ, Dept Internal Med, Chunchon, South Korea
Hallym Univ, Ctr Liver & Digest Dis, Chunchon, South Korea


[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Kim, Hong Soo
(Kim, HS)
Soonchunhyang Univ, Dept Internal Med, Coll Med, Cheonan, South Korea HQZ-0240-2023
Kim, Yong-Tae

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Kim, Hyeong Seop
(Kim, HS)
Hallym Univ, Inst Liver & Digest Dis, Coll Med, 1 Hallymdaehak Gil, Chunchon 24252, South Korea

[JCR상위 19.9] Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY bykim@chunlab.com;ktsuk@hallym.ac.kr;
Kim, Ju Hyun
(Kim, JH)
Gacheon Univ, Dept Internal Med, Coll Med, Incheon, South Korea K-7697-2013
Kim, Hyun

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Kim, Kyun-Hwan
(Kim, KH)
Sungkyunkwan Univ, Sch Med, Dept Precis Med, Suwon, South Korea

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
페이지 이동: